NIH-funded research R01 grant

Understanding long-lasting COVID-19 in immunosuppressed individuals

Official title: Characterization of Persistent COVID-19

Funded at Brigham and Women's Hospital · NIH-10904944 · Data updated 2026-11-12

This study is looking at how long-lasting COVID-19 infections impact people with weakened immune systems, aiming to understand their immune responses and how new virus variants might develop, so we can better support and treat these individuals.

More COVID-19 research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 10, 2023
Project endJuly 31, 2027
Funding year2024
Award (this year)$846,387
NIH project number5R01AI176287-02
Project IDNIH-10904944 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are immunosuppressed individuals who have experienced chronic COVID-19 infections.

Less likely to help

Patients who are not immunosuppressed or who have not experienced chronic COVID-19 infections may not benefit from this research.

What this research studies

This research investigates how chronic COVID-19 infections affect immunosuppressed individuals, who are at higher risk for severe disease and treatment failure. The study aims to identify the immune and viral mechanisms that contribute to prolonged infections and the emergence of new COVID-19 variants. By utilizing a translational research infrastructure, the team will recruit cohorts of these high-risk patients and analyze their immune responses, viral loads, and genetic variations. The findings will help improve clinical care and treatment strategies for this vulnerable population.

Why it matters

Potential benefit: If successful, this research could lead to better treatment options and improved health outcomes for immunosuppressed patients suffering from chronic COVID-19.

How similar studies have gone: Other research has shown success in understanding chronic infections and their implications, but this specific focus on immunosuppressed individuals and COVID-19 variants is relatively novel.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Li, Jonathan — Brigham and Women's Hospital
  • Study coordinator: Li, Jonathan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.